Solcoseryl

Available in many countries outside the US for wound healing and mucosal repair. Evidence quality is moderate, largely from European and Asian studies.

A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.

Clinical studies in dental ulcer healing, wound repair, and peripheral vascular disease. Not FDA-approved. Approved in various forms (topical, injectable) in multiple countries.

• Accelerated wound healing in dental and dermal studies
• Improved tissue oxygenation in preclinical models
• Available in topical and injectable forms in multiple countries

Topical: apply gel or ointment 2–3 times daily. Injectable: 2–4 mL IM or IV per clinical protocol.

• Local burning with topical application
• Allergic reactions rare
• Injection-site pain

Animal-derived product. Theoretical prion risk. Not available in the US or UK.

Clinical evidence is moderate but dated. Modern formulation consistency across manufacturers may vary.

• Recovery30